Over the last 7 days, the Life Sciences industry has risen 1.9%, driven by gains from Lonza Group of 0.7%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 19% annually.
Has the Swiss Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 12 Jul 2025 | CHF 53.1b | CHF 10.1b | CHF 1.0b | 33.8x | 51.1x | 5.3x |
Mon, 09 Jun 2025 | CHF 53.4b | CHF 10.1b | CHF 1.0b | 32.2x | 51.4x | 5.3x |
Wed, 07 May 2025 | CHF 54.2b | CHF 10.1b | CHF 1.0b | 30.3x | 52.2x | 5.4x |
Fri, 04 Apr 2025 | CHF 50.5b | CHF 10.1b | CHF 1.0b | 29.9x | 49.2x | 5x |
Sun, 02 Mar 2025 | CHF 54.5b | CHF 10.1b | CHF 1.0b | 31.2x | 52.2x | 5.4x |
Tue, 28 Jan 2025 | CHF 57.2b | CHF 10.2b | CHF 943.2m | 36.4x | 60.6x | 5.6x |
Thu, 26 Dec 2024 | CHF 52.4b | CHF 10.2b | CHF 943.5m | 35.4x | 55.5x | 5.1x |
Sat, 23 Nov 2024 | CHF 52.9b | CHF 10.2b | CHF 943.7m | 40.8x | 56.1x | 5.2x |
Mon, 21 Oct 2024 | CHF 56.1b | CHF 10.2b | CHF 943.4m | 42.3x | 59.5x | 5.5x |
Wed, 18 Sep 2024 | CHF 56.2b | CHF 10.2b | CHF 937.0m | 44.1x | 60x | 5.5x |
Fri, 16 Aug 2024 | CHF 56.8b | CHF 10.2b | CHF 914.5m | 45.4x | 62.1x | 5.6x |
Sun, 14 Jul 2024 | CHF 55.4b | CHF 10.3b | CHF 1.0b | 47.5x | 55.3x | 5.4x |
Tue, 11 Jun 2024 | CHF 53.1b | CHF 10.3b | CHF 1.0b | 43.6x | 53x | 5.2x |
Thu, 09 May 2024 | CHF 55.0b | CHF 10.3b | CHF 1.0b | 43.6x | 54.9x | 5.4x |
Sat, 06 Apr 2024 | CHF 57.1b | CHF 10.3b | CHF 1.0b | 45.4x | 56.9x | 5.6x |
Mon, 04 Mar 2024 | CHF 50.7b | CHF 10.2b | CHF 982.2m | 47x | 51.7x | 5x |
Wed, 31 Jan 2024 | CHF 47.0b | CHF 10.2b | CHF 1.0b | 41.6x | 46.1x | 4.6x |
Fri, 29 Dec 2023 | CHF 41.8b | CHF 9.8b | CHF 1.5b | 32.4x | 28x | 4.3x |
Sun, 26 Nov 2023 | CHF 41.4b | CHF 9.8b | CHF 1.5b | 29.9x | 27.7x | 4.2x |
Tue, 24 Oct 2023 | CHF 37.8b | CHF 9.8b | CHF 1.5b | 26.5x | 25.3x | 3.9x |
Thu, 21 Sep 2023 | CHF 48.2b | CHF 9.8b | CHF 1.5b | 33.4x | 32.3x | 4.9x |
Sat, 19 Aug 2023 | CHF 51.5b | CHF 9.7b | CHF 1.5b | 40.3x | 33.6x | 5.3x |
Mon, 17 Jul 2023 | CHF 56.4b | CHF 9.7b | CHF 1.6b | 36.1x | 34.5x | 5.8x |
Wed, 14 Jun 2023 | CHF 59.0b | CHF 9.7b | CHF 1.6b | 37.5x | 36.1x | 6.1x |
Fri, 12 May 2023 | CHF 60.7b | CHF 9.7b | CHF 1.6b | 40x | 37.1x | 6.3x |
Sun, 09 Apr 2023 | CHF 59.4b | CHF 9.7b | CHF 1.7b | 41.6x | 35.6x | 6.1x |
Tue, 07 Mar 2023 | CHF 59.6b | CHF 9.6b | CHF 1.7b | 34.4x | 35.9x | 6.2x |
Thu, 02 Feb 2023 | CHF 55.0b | CHF 9.6b | CHF 1.6b | 31.8x | 33.6x | 5.8x |
Sat, 31 Dec 2022 | CHF 50.7b | CHF 9.2b | CHF 1.3b | 37x | 38.1x | 5.5x |
Mon, 28 Nov 2022 | CHF 54.9b | CHF 9.2b | CHF 1.3b | 41.1x | 41.3x | 6x |
Wed, 26 Oct 2022 | CHF 54.0b | CHF 9.2b | CHF 1.3b | 42.3x | 40.6x | 5.9x |
Fri, 23 Sep 2022 | CHF 47.8b | CHF 9.2b | CHF 1.3b | 37.2x | 37x | 5.2x |
Sun, 21 Aug 2022 | CHF 56.8b | CHF 9.0b | CHF 1.3b | 41.4x | 44.4x | 6.3x |
Tue, 19 Jul 2022 | CHF 56.3b | CHF 8.5b | CHF 1.1b | 34.1x | 52.2x | 6.6x |
52.2x
Which industries have driven the changes within the Swiss Healthcare industry?
CH Market | 1.46% | |
Healthcare | 2.52% | |
Life Sciences | 1.89% | |
Clinical Research and Equipment | 1.89% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
LONN Lonza Group | CHF 564.00 | 0.7% +CHF 268.4m | 8.9% | PE62.6x | |
SKAN SKAN Group | CHF 72.50 | 2.1% +CHF 33.7m | -9.5% | PE42x |